Renāte Ranka

Exploring Variability in Rifampicin Plasma Exposure and Development of Anti-Tuberculosis Drug-Induced Liver Injury among Patients with Pulmonary Tuberculosis from the Pharmacogenetic Perspective

S. Grinberga, Eduards Sevostjanovs, M. Zolovs, 2024, Pharmaceutics.

Pediatric and adolescent tuberculosis in Latvia, 2011-2014: case detection, diagnosis and treatment.

R. Ranka, I. Ozere, B. Ziemele, 2017, The International Journal of Tuberculosis and Lung Disease.

Effect of NAT2, GSTM1 and CYP2E1 genetic polymorphisms on plasma concentration of isoniazid and its metabolites in patients with tuberculosis, and the assessment of exposure-response relationships

Dace Bandere, S. Grinberga, Leonora Pahirko, 2024, Frontiers in pharmacology.